Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 289,590 | 3,124 | 40,997 | 5,164 | 247 |
| Gross Profit | 289,590 | 3,124 | 40,997 | 5,164 | 247 |
| Operating Expenses | 242,850 | 162,067 | 105,645 | 73,294 | 25,976 |
| Operating Income | 46,740 | -158,943 | -64,648 | -68,130 | -25,729 |
| Interest Expense | 0 | 0 | 0 | 8,050 | 108 |
| Other Income | 20,566 | -5,485 | -1,960 | 53,462 | 16 |
| Pre-tax Income | 67,306 | -164,428 | -66,608 | -22,718 | -25,821 |
| Income Tax | 448 | 553 | 1,749 | 484 | 7 |
| Net Income Continuous | 66,858 | -164,981 | -68,357 | -23,202 | -25,828 |
| Minority Interests | N/A | N/A | N/A | -25 | -325 |
| Net Income | $66,858 | $-164,981 | $-68,357 | $-23,177 | $-25,503 |
| EPS Basic Total Ops | 1.23 | -3.44 | -1.71 | -1.89 | -5.06 |
| EPS Basic Continuous Ops | 1.23 | -3.44 | -1.71 | -1.89 | -5.13 |
| EPS Diluted Total Ops | 1.17 | -3.44 | -1.71 | -1.89 | -5.06 |
| EPS Diluted Continuous Ops | 1.17 | -3.44 | -1.71 | -1.89 | -5.13 |
| EPS Diluted Before Non-Recurring Items | 1.17 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $51,465 | $-155,424 | $-61,624 | $-67,205 | $-25,602 |